Arnicare Cream Value Pack
- Manufacturer
- Laboratoires Boiron | Boiron Inc. | Boiron
- Effective date
- 2025-12-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 14
- Source
- full-release
- Hydrated at
- 2026-06-01 02:35:55
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients**
Arnicare Cream:
Arnica Montana 1X HPUS 7%
Arnica 30C pellets: (in each pellet)
Arnica montana 30C HPUS (0.44 mg)
The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Purpose*
Arnicare Cream: Arnica Montana 1X HPUS 7% Relieves minor muscle pain & stiffness, swelling from injuries, discoloration from bruises
Arnica 30 C pellets: Arnica montana 30C HPUS (0.44 mg) Relieves minor muscle pain & stiffness, swelling from injuries, discoloration from bruises
INDICATIONS & USAGE SECTION
Uses*
- temporarily relieves minor muscle pain and stiffness due to:
- minor injuries
- overexertion
- falls
- reduces symptoms of bruising such as:
- pain
- swelling
- discoloration
WARNINGS SECTION
Arnicare Cream:
For external use only.
OTC - DO NOT USE SECTION
Do not use if you are allergic to Arnica montana or to any of this product's inactive ingredients.
OTC - WHEN USING SECTION
When using this product
- avoid contact with eyes, mucous membranes, wounds, damaged or irritated skin
- use only as directed
- do not tightly wrap or bandage the treated area
- do not apply heat or ice to the treated area before or after use
OTC - STOP USE SECTION
Stop use and ask a doctor if
- condition persists for more than 3 days or worsens
- symptoms clear up and occur again within a few days
ARNICA 30 PELLETS:
Stop use and ask a doctor if symptoms persists for more than 3 days or worsen.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
DOSAGE & ADMINISTRATION SECTION
ARNICARE CREAM:
- Adults and children 1 year of age and older: Apply a thin layer of Arnicare Cream to affected area and massage gently as soon as possible after minor injury up to 3 times a day. If heat or ice is applied, wait 5 minutes before applying Arnicare Cream.
- Children under 1 year of age: Not recommended.
ARNICA 30C PELLETS:
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
INACTIVE INGREDIENT SECTION
ARNICARE CREAM: arachidyl alcohol, arachidyl glucoside, behenyl alcohol, Butyrospermum parkii (Shea) butter, coconut oil, glycerin, lactobacillus ferment, purified water, xanthan gum
ARNICA 30C PELLETS: lactose, sucrose
OTC - QUESTIONS SECTION
Arnicare.com
BoironUSA.com
Info@Boiron.com
1-800-BOIRON-1
(1-800-264-7661)
Distributed by Boiron Inc.
Newtown Square, PA 19073
SPL UNCLASSIFIED SECTION
do not use if glued end flaps are open or if pellet dispenser seal is broken
ARNICARE CREAM: dispose of 1 year after opening
retain carton for full drug facts
How to use Arnica 30C Pellets Turn tube upside down Twist until 5 pellets are dispensed Remove cap and pour pellets under tongue
2.5 oz (70 g)
+ Approx. 80 pellets
meltaway pellets
Pain Relief*
Muscle Pain & Stiffness Swelling from Injuries Bruises*
Local & General Muscle Pain
No known drug interactions
ɨ Homeopathic mother tincture made from Arnica montana fresh whole plant.
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
**C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-9047-78 | Arnica Value Pack | 1 in 1 BOX | KIT | 1 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0220-9021-60 | GM - Gram | 0220-9021 | 81539eba-887c-421c-b1dc-82aa193727c6 | 1 | 2024-05-16 |
| 0220-9021-63 | GM - Gram | 0220-9021 | d381223e-d0c6-4f23-8399-bd7285056915 | 1 | 2021-02-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARNICA MONTANA | ACTIVE INGREDIENT | O80TY208ZW | 6 | |
| ARNICA MONTANA | ACTIVE MOIETY | O80TY208ZW | 6 | |
| 1,2-HEXANEDIOL | INACTIVE INGREDIENT | TR046Y3K1G | 6 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 6 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 6 | |
| CARBOMER 934 | INACTIVE INGREDIENT | Z135WT9208 | 6 | |
| CETYL PALMITATE | INACTIVE INGREDIENT | 5ZA2S6B08X | 6 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 6 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 6 | |
| HYDROGENATED PALM KERNEL OIL | INACTIVE INGREDIENT | FM8D1RE2VP | 6 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 6 | |
| PEGOXOL 7 STEARATE | INACTIVE INGREDIENT | 3EW5AXE5X5 | 6 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 6 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | 6 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Products#
Every source-derived product name is available through these pages.
- Arnica Value Pack
- ARNICA MONTANA
- Arnica
- SUCROSE
- LACTOSE
- ARNICARE
- GLYCERIN
- ARACHIDYL ALCOHOL
- WATER
- XANTHAN GUM
- BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES
- DOCOSANOL
- LIMOSILACTOBACILLUS FERMENTUM
- ARACHIDYL GLUCOSIDE
- COCONUT OIL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-9047 | 0220-9047-78 |
| 0220-0508 | |
| 0220-9021 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SUCROSE | C151H8M554 | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| ARNICA MONTANA | O80TY208ZW | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| ARACHIDYL ALCOHOL | 1QR1QRA9BU | IACT |
| WATER | 059QF0KO0R | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES | 0C9AC7D6XU | IACT |
| ARNICA MONTANA | O80TY208ZW | ACTIB |
| DOCOSANOL | 9G1OE216XY | IACT |
| LIMOSILACTOBACILLUS FERMENTUM | 2C1F12C6AP | IACT |
| ARACHIDYL GLUCOSIDE | 6JVW35JOOJ | IACT |
| COCONUT OIL | Q9L0O73W7L | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| CARBOMER 934 | CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) | Z135WT9208 | CREAM / TOPICAL | 600 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | CREAM / TOPICAL | 640 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| CETYL PALMITATE | CETYL PALMITATE | 5ZA2S6B08X | CREAM / TOPICAL | 0.32 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| SORBIC ACID | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ARNICARE | ARNICA MONTANA | Laboratoires Boiron | 542b41dd-f285-4e48-a67b-8e69523b143a | 2026-05-20 | Warnings | 0220-9021 |
| Arnica | ARNICA MONTANA | Laboratoires Boiron | 1ce3fd1f-24f8-491c-a0ae-087ea3d20040 | 2025-12-29 | 0220-0508 | |
| Arnica Value Pack | ARNICA MONTANA | Laboratoires Boiron | eeff33a9-44a7-413e-bae6-8183ef9a399f | 2025-12-15 | Warnings | 0220-9047-78 0220-9047 00220904778 4600f988-da06-56b7-e063-6394a90afd04 eeff33a9-44a7-413e-bae6-8183ef9a399f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.








